Company intelligence / Profile preview

Equine Amnio Solutions

Argyle, Texas, United Statesrenovoequine.com ↗

Ownership: Private
Employees: ~30
Development stage: Other

Overview

RenoVō®, the company's flagship product, is a cryopreserved, acellular allograft derived from equine amniotic tissues used in over 17,000 horses. Published and field studies in over 200 horses show safety and efficacy in soft tissue and orthopedic injuries, supporting rapid clinical adoption in veterinary care[1][4][6].

Therapeutic areas: Other
Modalities: BiologicAllograft
Industry: Veterinary

Partnerships

Covetrus (exclusive US distributor)[1]Equus Innovations (product manufacturer and R&D partner)[1][4][6]

Beyond the preview

Go deeper on Equine Amnio Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Equine Amnio Solutions.